We are live on ! Find out more
NRC icon

NRC Health Common Stock

126 hedge funds and large institutions have $196M invested in NRC Health Common Stock in 2025 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 42 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,000% more call options, than puts

Call options by funds: $31K | Put options by funds: $1K

33% more capital invested

Capital invested by funds: $147M → $196M (+$48.8M)

21% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 19

2% more funds holding

Funds holding: 123126 (+3)

1.1% more ownership

Funds ownership: 50.12%51.22% (+1.1%)

5% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 42

Holders
126
Holders Change
+3
Holders Change %
+2.44%
% of All Funds
1.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
23
Increased
44
Reduced
42
Closed
19
Calls
$31K
Puts
$1K
Net Calls
+$30K
Net Calls Change
+$21K
Name Holding Trade Value Shares
Change
Change in
Stake
SEI Investments
26
SEI Investments
Pennsylvania
$1.27M +$47.3K +3,500 +5%
Millennium Management
27
Millennium Management
New York
$904K +$159K +11,770 +28%
Bessemer Group
28
Bessemer Group
New Jersey
$791K
Ameriprise
29
Ameriprise
Minnesota
$780K +$130K +9,599 +26%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$733K +$243K +18,014 +70%
American Century Companies
31
American Century Companies
Missouri
$708K +$500 +37 +0.1%
WJWM
32
Williams Jones Wealth Management
New York
$706K
AA
33
ALPS Advisors
Colorado
$682K -$20.7K -1,532 -4%
US Bancorp
34
US Bancorp
Minnesota
$648K +$18.5K +1,372 +4%
N
35
Nuveen
North Carolina
$565K -$75.6K -5,598 -14%
AAM
36
Azzad Asset Management
Virginia
$548K -$9.19K -680 -2%
Two Sigma Investments
37
Two Sigma Investments
New York
$514K +$113K +8,351 +38%
Jane Street
38
Jane Street
New York
$505K -$302K -22,339 -43%
Qube Research & Technologies (QRT)
39
Qube Research & Technologies (QRT)
United Kingdom
$505K -$413K -30,563 -50%
Barclays
40
Barclays
United Kingdom
$495K +$92.6K +6,852 +30%
Neuberger Berman Group
41
Neuberger Berman Group
New York
$469K -$17.6K -1,303 -4%
LTAS
42
Linden Thomas Advisory Services
North Carolina
$463K -$6.13K -454 -2%
VPIM
43
Vanguard Personalized Indexing Management
California
$444K +$357K +26,432 New
QCM
44
Quantinno Capital Management
New York
$438K +$353K +26,092 New
Daiwa Securities Group
45
Daiwa Securities Group
Japan
$436K -$67.5K -5,000 -16%
Fidelity Investments
46
Fidelity Investments
Massachusetts
$425K +$252K +18,641 +279%
PMAM
47
Penn Mutual Asset Management
Pennsylvania
$425K +$67.5K +5,000 +25%
Los Angeles Capital Management
48
Los Angeles Capital Management
California
$403K +$324K +23,988 New
II
49
Inspire Investing
Idaho
$386K -$51K -3,774 -14%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$366K -$5.81K -430 -2%

NRC Hedge Fund Activity: Q2 2025 in Review

126 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q2 2025, worth a combined $196M — up 33% from $147M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new NRC positions and 19 closed out — a net gain of 4 holders — while 44 added to existing stakes and 42 trimmed.

The largest buyer was Willis Investment Counsel, adding an estimated $1.56M. The largest seller was Citadel Advisors, cutting an estimated $1.02M.

  • 126 institutional investors held NRC Health Common Stock (NRC) as of Q2 2025, up from 123 in Q1 2025.
  • Funds reported $196M of NRC Health Common Stock stock for Q2 2025, up 33% quarter-over-quarter.
  • 23 funds opened new NRC Health Common Stock positions in Q2 2025 and 19 closed out, a net change of +4 holders.
  • The largest NRC Health Common Stock buyer in Q2 2025 was Willis Investment Counsel, an estimated $1.56M added.
  • The largest NRC Health Common Stock seller in Q2 2025 was Citadel Advisors, an estimated $1.02M sold.

Based on aggregated 13F filings for Q2 2025.